MedPath

Effectiveness of Robotic Assisted Gait Training in Children With Cerebral Palsy

Not Applicable
Terminated
Conditions
Cerebral Palsy
Registration Number
NCT00887848
Lead Sponsor
University Children's Hospital, Zurich
Brief Summary

The purpose of the study is to investigate the effectiveness of robotic-assisted locomotor therapy on improvements of functional gait parameters in ambulatory children with cerebral palsy.

Detailed Description

Within a randomized controlled design the effects of robotic-assisted locomotor training (15 sessions within 5 weeks) will be examined in a sample of 34 children with cerebral palsy.

Children will be randomly assigned to an intervention or waiting list group. Assessments will be performed at baseline, in week 6 as well as in week 12. The intervention is provided to the waiting list group after the assessment in week 6.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Bilateral spastic cerebral palsy
  • Gross Motor Function Classification Scale (GMFCS) II-IV
Exclusion Criteria
  • Prior orthopedic surgery on the lower extremity or the trunk (<6 months)
  • Prior neurosurgical interventions (<6 months)
  • Significant mental retardation
  • Severe contractures
  • Prior Lokomat training (<6 months)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
GMFM-66, section Eweek 0, week 6, week 12
Secondary Outcome Measures
NameTimeMethod
GMFM-66, section Dweek 0, week 6, week 12
Gait speedweek 0, week 6, week 12
6-minute walk testweek 0, week 6, week 12
3D gait analysisweek 0, week 6

Trial Locations

Locations (2)

Paediatric Therapy Center Reha Rheinfelden

🇨🇭

Rheinfelden, Aargau, Switzerland

University Children's Hospital Zurich, Rehabilitation Centre Affoltern

🇨🇭

Affoltern am Albis, Switzerland

Paediatric Therapy Center Reha Rheinfelden
🇨🇭Rheinfelden, Aargau, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.